Effects of dorzolamide-timolol and brimonidine-timolol on retinal vascular autoregulation and ocular perfusion pressure in primary open angle glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 7, 2013, Pages 639-645

  Feke, Gilbert T ^a   Rhee, Douglas J ^a   Turalba, Angela V ^a   Pasquale, Louis R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE PLUS TIMOLOL; DORZOLAMIDE PLUS TIMOLOL;

ADULT; AGED; ARTICLE; AUTOREGULATION; BLOOD FLOWMETER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EYE BLOOD FLOW; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER FLOWMETER; MALE; OPEN ANGLE GLAUCOMA; PERFUSION PRESSURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; RETINA BLOOD FLOW; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CROSS-OVER STUDIES; DRUG COMBINATIONS; EYE; FEMALE; GLAUCOMA, OPEN-ANGLE; HOMEOSTASIS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOXALINES; REGIONAL BLOOD FLOW; SULFONAMIDES; THIOPHENES; TIMOLOL;

EID: 84883261715     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0271     Document Type: Article

References (48)

1. Feke, G.T., and Pasquale, L.R. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 115:246-252, 2008.
2. Pasquale, L.R., Jonas, J., and Anderson, D.R. Anatomy and physiology. In: Weinreb, R.N., Harris, A., eds. Ocular Blood flow in Glaucoma. Amsterdam: Kugler Publications; 2009; pp. 3-13.
3. Prünte, C., Orgül, S., and Flammer, J. Abnormalities of microcirculation in glaucoma: facts and hints. Curr. Opin. Ophthalmol. 9:50-55, 1998.
4. Flammer, J., Haefliger, I.O., Orgül, S., and Resink, T. Vascular dysregulaton: a principal risk factor for glaucomatous damage? J. Glaucoma 8:212-219, 1999.
5. Flammer, J., Pache, M., and Resink, T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog. Retin Eye Res. 20:319-349, 2001.
6. Grieshaber, M.C., and Flammer, J. Blood flow in glaucoma. Curr. Opin. Ophthalmol. 16:79-83, 2005.
7. Delaney, Y., Walshe, T.E., and O' Brien, C. Vasospasm in glaucoma: clinical and laboratory aspects. Optom. Vis. Sci. 83:406-414, 2006.
8. Tielsch, J.M., Katz, J., Sommer, A., Quigley, H.A., and Javitt, J.C. Hypertension, perfusion pressure, and primary openangle glaucoma. A population-based assessment. Arch. Ophthalmol. 113:216-221, 1995.
9. Bonomi, L., Marchini, G., Marraffa, M., et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt study. Ophthalmology 107:1287-1293, 2000.
10. Leske, M.C., Heijl, A., Hyman, L., et al. Predictors of longterm progression in the Early Manifest Glaucoma Trial. Ophthalmology 114:1965-1972, 2007.
11. Choi, J., Kim, K.H., Jeong, J., et al. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest. Ophthalmol. Vis. Sci. 48:104-111, 2007.
12. Sung, K.R., Lee, S., Park, S.B., et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal tension glaucoma progression. Invest. Ophthalmol. Vis. Sci. 50:5266-5274, 2009.
13. Grieshaber, M.C., Terhorst, T., and Flammer, J. The pathogenesis of optic disc splinter haemorrhages: a new hypothesis. Acta Ophthalmol. Scand. 84:62-68, 2006.
14. Budenz, D.L., Anderson, D.R., Feuer, W.J., et al. Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113:2137-2143, 2006.
15. Drance, S.M., Fairclough, M., Butler, D.M., and Kottler, M.S. The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma. Arch. Ophthalmol. 95:226-228, 1977.
16. Siegner, S.W., and Netland, P.A. Optic disc hemorrhages and progression of glaucoma. Ophthalmology 103:1014-1024, 1996.
17. Drance, S., Anderson, D.R., Schulzer M; Collaborative Normal- Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am. J. Ophthalmol. 131:699-708, 2001.
18. Leske, M.C., Heijl, A., Hussein, M., et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 121:48-56, 2003.
19. Kim, S.H., and Park, K.H. The relationship between recurrent optic disc hemorrhage and glaucoma progression. Ophthalmology 113:598-602, 2006.
20. Feke, G.T., Hazin, R., Grosskreutz, C.L., and Pasquale, L.R. Effect of brimonidine on retinal blood flow autoregulation in primary open-angle glaucoma. J. Ocul. Pharmacol. Ther. 27:347-352, 2011.
21. Reber, F., Gersch, U., and Funk, R.W. Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular and increase of intracellular pH in rat retinal organ culture. Graefes Arch. Clin. Exp. Ophthalmol. 241:140-148, 2003.
22. Rosa, R.H., Hein, T.W., Yuan, Z., et al. Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: diminished nitric oxide-mediated vasodilation when size goes small. Am. J. Physiol. Heart Circ. Physiol. 291:231-238, 2006.
23. Kadam, R.S., Jadhav, G., Ogidigben, M., and Kompella, U.B. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow. Drug Metab. Dispos. 39:1529- 1537, 2011.
24. Kent, A.R., Nussdorf, J.D., David, R., et al. Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology 108:784-787, 2001.
25. Costa, V.P., Harris, A., Stefansson, E., et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog. Retin Eye Res. 22:769-805, 2003.
26. Riva, C.E., Grunwald, J.E., and Petrig, B.L. Autoregulaton of human retinal blood flow: an investigation with laser Doppler velocimetry. Invest. Ophthalmol. Vis. Sci. 27:1706-1712, 1986.
27. Yoshida, A., Feke, G.T., Mori, F., et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am. J. Ophthalmol. 135:356-361, 2003.
28. El Beltagi, T.A., Bowd, C., Boden, C., et al. Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology 110:2185-2191, 2003.
29. Jandrasits, K., Polak, K., Luksch, A., et al. Effects of atropine and propranolol on retinal vessel diameters during isometric exercise. Ophthalmic Res. 33:185-190, 2001.
30. Hague, S., and Hill, D.W. Postural changes in perfusion pressure and retinal arteriolar caliber. Br. J. Ophthalmol. 72:253-257, 1988.
31. Wozniak, K., Köller, A.U., Spörl, E., Bohm, A.G., and Pillunat, L.E. Intraocular pressure measurement during the day and night for glaucoma patients and normal controls using Goldmann and Perkins applanation tonometry. Ophthalmologe 103:1027-1031, 2006.
32. Anderson, A.J., and Vingrys, A.J. Small samples: does size matter? Invest. Ophthalmol. Vis. Sci. 42:1411-1413, 2001.
33. Harris, A., Jonescu-Cuypers, C.P., Kagemann, L., et al. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular blood flow in patients with primary open angle glaucoma. Am. J. Ophthalmol. 132:490-495, 2001.
34. Uva, M.G., Longo, A., Reibaldi, M., and Reiobaldi, A. The effects of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma. Am. J. Ophthalmol. 141:1158-1160, 2006.
35. Siesky, B., Harris, A., Cantor, L.B., et al. A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma. Br. J. Ophthalmol. 92:500-504, 2008.
36. Siesky, B., Harris, A., Brizendine, E., et al. Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow. Surv. Ophthalmol. 54:33-46, 2009.
37. Siesky, B., Harris, A., Kagemann, L., et al. Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Acta Ophthalmol. 88:142-149, 2010.
38. Nagel, E., Vilser, W., and Lanzl, I. Dorzolamide influences the autoregulation of major retinal vessels caused by artificial intraocular pressure elevation in patients with POAG: a clinical study. Curr. Eye Res. 30:129-137, 2005.
39. Venkataraman, S.T., Hudson, C., Rachmiel, R., et al. Retinal arteriolar vascular reactivity in untreated and progressive primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 51:2043-2050, 2010.
40. Schmidt, K.G., Kingmüller, V., Gouveia, S.M., et al. Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients. Am. J. Ophthalmol. 136:1038-1048, 2003.
41. Inan, Ü.Ü., Ermis, S.S., Orman, A., et al. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. J. Ocul. Pharmacol. Ther. 20:293-310, 2004.
42. Carlsson, A.M., Chauhan, B.C., Lee, A.A., et al. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Am. J. Ophthalmol. 129:297-301, 2000.
43. Jonescu-Cuypers, C.P., Harris, A., Ishii, Y., et al. Effect of briminodine tartrate on ocular hemodynamics in healthy volunteers. J. Ocul. Pharmacol. Ther. 17:199-205, 2001.
44. Hatanaka, M., Grigera, D.E., BarbosaWL, Jordao, M., and Susanna, R. An eight-week multicentric, randomized, interventional, open-label, Phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% vs fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. J. Glaucoma 17:674-679, 2008.
45. Boltz, A., Schmidl, D., Weigert, G., et al. Effect of latanoprost on choroidal blood flow regulation in healthy subjects. Invest. Ophthalmol. Vis. Sci. 52:4410-4415, 2011.
46. Fuchsjäger-Mayrl, G., Georgopoulos, M., Hommer, A., et al. Effect of dorzolamide and timolol on ocular pressure:blood flow relationship in patients with primary open-angle glaucoma and ocular hypertension. Invest. Ophthalmol. Vis. Sci. 51:1289-1296, 2010.
47. Sponsel, W.E., Harrison, J., Elliott, W.R., et al. Dorzolamide hydrochloride and visual function in normal eyes. Am. J. Ophthalmol. 123:759-766, 1997.
48. Stewart, W.C., Holmes, K.T., and Johnson, M.A. Washout periods for brimonidine 0.2% and latanoprost 0.005%. Am. J. Ophthalmol. 131:798-799, 2001.